Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gel-Sinuplasty for Chronic Rhinosinusitis
NCT03472144Phase 3Unknown
- Sponsor
- LifeBridge Health
- Start
- Jul 2017
- Primary completion
- Jul 2019
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Mometasone furoate nano-nasal spray, levofloxacin in chronic rhinosinusitis (CRS), sponsored by LifeBridge Health. Status: unknown.
02
Drugs
Mometasone furoate nano-nasal spraylevofloxacin
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT03472144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03472144.